Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Regulation of adrenal steroidogenesis by the high-affinity phosphodiesterase 8 family.

Tsai LC, Beavo JA.

Horm Metab Res. 2012 Sep;44(10):790-4. doi: 10.1055/s-0032-1321861. Epub 2012 Aug 17. Review.

2.

The high-affinity cAMP-specific phosphodiesterase 8B controls steroidogenesis in the mouse adrenal gland.

Tsai LC, Shimizu-Albergine M, Beavo JA.

Mol Pharmacol. 2011 Apr;79(4):639-48. doi: 10.1124/mol.110.069104. Epub 2010 Dec 27.

3.

The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis.

Tsai LC, Beavo JA.

Curr Opin Pharmacol. 2011 Dec;11(6):670-5. doi: 10.1016/j.coph.2011.09.003. Epub 2011 Sep 29. Review.

4.

Studying mechanisms of cAMP and cyclic nucleotide phosphodiesterase signaling in Leydig cell function with phosphoproteomics.

Golkowski M, Shimizu-Albergine M, Suh HW, Beavo JA, Ong SE.

Cell Signal. 2016 Jul;28(7):764-78. doi: 10.1016/j.cellsig.2015.11.014. Epub 2015 Nov 28.

PMID:
26643407
5.

cAMP-specific phosphodiesterases 8A and 8B, essential regulators of Leydig cell steroidogenesis.

Shimizu-Albergine M, Tsai LC, Patrucco E, Beavo JA.

Mol Pharmacol. 2012 Apr;81(4):556-66. doi: 10.1124/mol.111.076125. Epub 2012 Jan 9.

6.

PDE8 regulates rapid Teff cell adhesion and proliferation independent of ICER.

Vang AG, Ben-Sasson SZ, Dong H, Kream B, DeNinno MP, Claffey MM, Housley W, Clark RB, Epstein PM, Brocke S.

PLoS One. 2010 Aug 9;5(8):e12011. doi: 10.1371/journal.pone.0012011.

7.

Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.

Richter W, Unciuleac L, Hermsdorf T, Kronbach T, Dettmer D.

Cell Signal. 2001 Mar;13(3):159-67.

PMID:
11282454
8.

Phosphodiesterase 8B and cyclic AMP signaling in the adrenal cortex.

Leal LF, Szarek E, Faucz F, Stratakis CA.

Endocrine. 2015 Sep;50(1):27-31. doi: 10.1007/s12020-015-0621-y. Epub 2015 May 14. Review.

PMID:
25971952
9.

Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase.

Soderling SH, Bayuga SJ, Beavo JA.

Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8991-6.

11.

Porcine detrusor cyclic nucleotide phosphodiesterase isoenzymes: characterization and functional effects of various phosphodiesterase inhibitors in vitro.

Truss MC, Uckert S, Stief CG, Schulz-Knappe P, Hess R, Forssmann WG, Jonas U.

Urology. 1995 May;45(5):893-901.

PMID:
7747383
12.

Distribution and function of 3',5'-Cyclic-AMP phosphodiesterases in the human ovary.

Petersen TS, Kristensen SG, Jeppesen JV, Grøndahl ML, Wissing ML, Macklon KT, Andersen CY.

Mol Cell Endocrinol. 2015 Mar 5;403:10-20. doi: 10.1016/j.mce.2015.01.004. Epub 2015 Jan 8.

PMID:
25578602
13.

Phosphodiesterase 4 regulation of cyclic AMP in pulmonary remodelling: potential roles for isoform selective inhibitors.

Shepherd MC.

Pulm Pharmacol Ther. 2006;19(1):24-31. Epub 2005 Jul 20. Review. No abstract available.

PMID:
16046159
14.

Exposure to an Extremely-Low-Frequency Magnetic Field Stimulates Adrenal Steroidogenesis via Inhibition of Phosphodiesterase Activity in a Mouse Adrenal Cell Line.

Kitaoka K, Kawata S, Yoshida T, Kadoriku F, Kitamura M.

PLoS One. 2016 Apr 21;11(4):e0154167. doi: 10.1371/journal.pone.0154167. eCollection 2016.

15.

Carboxyamidotriazole: a novel inhibitor of both cAMP-phosphodiesterases and cGMP-phosphodiesterases.

Guo L, Luo L, Ju R, Chen C, Zhu L, Li J, Yu X, Ye C, Zhang D.

Eur J Pharmacol. 2015 Jan 5;746:14-21. doi: 10.1016/j.ejphar.2014.10.018. Epub 2014 Nov 11.

PMID:
25446933
18.

Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.

Ahlström M, Pekkinen M, Huttunen M, Lamberg-Allardt C.

Cell Mol Biol Lett. 2005;10(2):305-19.

19.

Phosphodiesterases and regulation of female reproductive function.

Conti M.

Curr Opin Pharmacol. 2011 Dec;11(6):665-9. doi: 10.1016/j.coph.2011.10.004. Epub 2011 Oct 21. Review.

PMID:
22019564
20.

Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).

Thompson WJ, Ashikaga T, Kelly JJ, Liu L, Zhu B, Vemavarapu L, Strada SJ.

Biochem Pharmacol. 2002 Feb 15;63(4):797-807.

PMID:
11992650

Supplemental Content

Support Center